Dorsey Wright & Associates Bicycle Therapeutics PLC Transaction History

Dorsey Wright & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$12.95 - $46.99 $1.64 Million - $5.97 Million	-126,982 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$40.12 - $59.5 $150,209 - $222,768	-3,744 Reduced 2.86%	126,982 $5.57 Million
Q4 2021 Jan 27, 2022	BUY	$41.7 - $61.14 $122,514 - $179,629	2,938 Added 2.3%	130,726 $7.96 Million
Q3 2021 Oct 26, 2021	BUY	$27.95 - $44.24 $59,058 - $93,479	2,113 Added 1.68%	127,788 $5.32 Million
Q2 2021 Jul 23, 2021	BUY	$27.0 - $32.28 $3.39 Million - $4.06 Million	125,675 New	125,675 $3.82 Million

30.6M

85.5K

11.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $581M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.